Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN119241385B reveals mild synthesis for high-purity amide intermediates. Achieve cost reduction in peptide manufacturing with scalable routes.
Patent CN107759458B details a metal-free synthesis of alpha-unsaturated ketones using DMSO. This method offers high yields, reduced costs, and eliminates heavy metal catalysts for reliable pharmaceutical intermediate supply.
Patent CN104650025A details a transition-metal-free method for benzoxepin synthesis, offering cost-effective and scalable solutions for pharmaceutical intermediate manufacturing.
Patent CN118834244B reveals advanced palladium complex enhancing Suzuki coupling efficiency. Offers supply chain stability and reduced purification costs for pharmaceutical manufacturers.
Novel nickel-catalyzed oxidation route for Acalabrutinib key intermediate reduces cost and pollution while ensuring high purity for pharma supply chains.
Patent CN111606785B details a green, Pd-free method for aryl internal alkynes using copper catalysis and visible light, offering significant cost and supply chain advantages.
Patent CN103406148A details high-activity NHC-Pd catalysts for aminocarbonylation. Discover cost-effective synthesis and scalable supply solutions for pharmaceutical intermediates.
Patent CN113735894B details a Cr-catalyzed route to chiral 2,3-allenols. Offers high enantioselectivity and scalable conditions for API intermediates.
Patent CN111217844B details a cost-effective 1,1-diboronation of olefins using Cp2ZrCl2. This method offers high atom economy and scalability for reliable pharmaceutical intermediate supply chains.
Patent CN108640807A reveals room temperature formylation method offering high yield and purity. This breakthrough enables cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN108129287B discloses a novel FeCl2-catalyzed radical cyclization of methylenecyclopropanes and aldehydes, offering a cost-effective route for high-purity pharmaceutical intermediates.
Patent CN107922305A details a novel one-pot Sonogashira coupling using fluorosulfonates, offering significant cost reduction and supply chain reliability for high-purity aromatic compounds.
Patent CN110396072B details a cost-effective dual-catalyst route for (S)-3-hydroxytetrahydrofuran, offering high optical purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN113563305B reveals a cost-effective, high-yield route for 2-(4-phenoxyphenyl)-6-(N-substituted oxycarbonyl piperidine-4-) nicotinamide, ensuring reliable supply chain stability.
Patent CN111574380A reveals a cost-effective reductive coupling route for diaminobiphenyls, offering high purity and scalable manufacturing for fine chemical intermediates.
Patent CN110407739B details a high-yield, one-pot synthesis of diaryl-tetrahydropyridines. This method offers 100% atom economy and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN102153501B reveals a metal-free organocatalytic route for chiral pyrrolidines and piperidines, offering significant cost reduction in API manufacturing and supply chain reliability.
Patent CN107417516A enables recycling still bottoms for D-2-chloropropionyl chloride. Enhances yield and supply continuity for pharmaceutical intermediate manufacturing partners.
Patent CN102898342A details a novel chiral hydroxyl amide synthesis offering 99% conversion in catalysis. Discover cost-effective manufacturing and supply advantages.
Patent CN110423215B reveals a novel chalcone pyridinium salt synthesis enabling efficient nitrogen-bridged ring construction with mild conditions and high purity.